Arcadia Biosciences
NasdaqCM:RKDA
$ 1,70
$-0,04 (-2,30%)
1,70 $
$-0,04 (-2,30%)
End-of-day quote: 03/23/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,00
Earnings Per Share
$3,69
Revenue Per Share
0,00%
Gross Margin %
$0,00 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$0,00
Revenue Per Share
$3,69
Gross Margin %
0,00%
Market Cap
$0,00 B
Long-Term Debt
$0,00 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share $-5,17 $-5,17 $-11,30 $-25,65 $-27,60 $-18,80 $-181,20 $-143,20 $-291,20 $-352,00 $-584,00
Earnings Earnings $-7,08M $-7,08M $-15,37M $-22,06M $-15,18M $-9,96M $-39,86M $-17,18M $-14,56M $-21,12M $-35,04M
RPS Revenue Per Share $3,69 $3,69 $3,92 $11,58 $12,33 $15,15 $5,32 $12,17 $80,60 $53,17 $90,17
Revenue Revenue $5,05M $5,05M $5,33M $9,96M $6,78M $8,03M $1,17M $1,46M $4,03M $3,19M $5,41M
OCF Operating Cash Flow $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $-17,06M $-15,11M
FCF Free Cash Flow $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% -147,83% -251,80% -190,43% 0,00% -214,26% 0,00% 0,00% 0,00% 0,00% -287,46%
GM % Gross Margin % 0,00% 43,29% 20,39% 12,27% -32,80% -10,13% 0,00% 0,00% -91,01% -199,81% -82,08%
FCFS Free Cash Flow Per Share $0,00 $-4,14 $-12,37 $-23,44 $-50,52 $-130,75 $-117,40 $-147,42 $-260,53 $-311,69 $-427,46
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 1,37M 1,37M 1,36M 0,86M 0,55M 0,53M 0,22M 0,12M 0,05M 0,06M 0,06M
×